6GQ3 | pdb_00006gq3

Human asparagine synthetase (ASNS) in complex with 6-diazo-5-oxo-L-norleucine (DON) at 1.85 A resolution

External Resource: Annotation

Domain Annotation: ECOD Classification
Domain Annotation: CATH
Protein Family Annotation
Gene Ontology: Gene Product Annotation
InterPro: Protein Family Classification
Pharos: Disease Associations

Domain Annotation: ECOD Classification ECOD Database Homepage

Chains	Family Name	Domain Identifier	Architecture	Possible Homology	Homology	Topology	Family	Provenance Source (Version)
B	Hydrolase	e6gq3B1	A: a/b three-layered sandwiches	X: P-loop domains-like	H: DUF1107-like	T: DUF1107-like	F: Hydrolase	ECOD (v294.1)
A	MAM33	e6gq3A1	A: a/b three-layered sandwiches	X: P-loop domains-like	H: Hemagglutinin HA2 chain	T: Hemagglutinin HA2 chain	F: MAM33	ECOD (v294.1)

Domain Annotation: CATH CATH Database Homepage

Chain	Domain	Class	Architecture	Topology	Homology	Provenance Source (Version)
B	3.40.50.620	Alpha Beta	3-Layer(aba) Sandwich	Rossmann fold	HUPs	CATH (utative)
A	3.40.50.620	Alpha Beta	3-Layer(aba) Sandwich	Rossmann fold	HUPs	CATH (utative)

Protein Family Annotation Pfam Database Homepage

Chains	Accession	Name	Description	Comments	Source
A, B	PF00733	Asparagine synthase (Asn_synthase)	Asparagine synthase	This family is always found associated with Pfam:PF00310. Members of this family catalyse the conversion of aspartate to asparagine.	Domain
A, B	PF13537	Glutamine amidotransferase domain (GATase_7)	Glutamine amidotransferase domain	This domain is a class-II glutamine amidotransferase domain found in a variety of enzymes such as asparagine synthetase and glutamine-fructose-6-phosphate transaminase.	Domain

Gene Ontology: Gene Product Annotation Gene Ontology Database Homepage

Chains	Polymer	Molecular Function	Biological Process	Cellular Component
A, B	Asparagine synthetase [glutamine-hydrolyzing]	binding adenyl ribonucleotide binding nucleotide binding purine ribonucleotide binding purine ribonucleoside triphosphate binding nucleoside phosphate binding ion binding purine nucleotide binding anion binding adenyl nucleotide binding ATP binding heterocyclic compound binding carbohydrate derivative binding ribonucleotide binding binding adenyl ribonucleotide binding nucleotide binding purine ribonucleotide binding purine ribonucleoside triphosphate binding nucleoside phosphate binding ion binding purine nucleotide binding anion binding adenyl nucleotide binding ATP binding heterocyclic compound binding carbohydrate derivative binding ribonucleotide binding small molecule binding carbon-nitrogen ligase activity, with glutamine as amido-N-donor asparagine synthase (glutamine-hydrolyzing) activity catalytic activity ligase activity, forming carbon-nitrogen bonds ligase activity	L-asparagine biosynthetic process oxoacid metabolic process aspartate family amino acid biosynthetic process amino acid metabolic process organic acid metabolic process organic acid biosynthetic process alpha-amino acid metabolic process carboxylic acid biosynthetic process small molecule metabolic process small molecule biosynthetic process carboxylic acid metabolic process L-amino acid biosynthetic process primary metabolic process L-amino acid metabolic process L-asparagine biosynthetic process oxoacid metabolic process aspartate family amino acid biosynthetic process amino acid metabolic process organic acid metabolic process organic acid biosynthetic process alpha-amino acid metabolic process carboxylic acid biosynthetic process small molecule metabolic process small molecule biosynthetic process carboxylic acid metabolic process L-amino acid biosynthetic process primary metabolic process L-amino acid metabolic process proteinogenic amino acid metabolic process amino acid biosynthetic process asparagine metabolic process biosynthetic process L-asparagine metabolic process proteinogenic amino acid biosynthetic process metabolic process cellular process alpha-amino acid biosynthetic process regulation of biological process regulation of cellular process negative regulation of programmed cell death regulation of apoptotic process biological regulation negative regulation of biological process regulation of programmed cell death cell death negative regulation of apoptotic process negative regulation of cellular process apoptotic process programmed cell death cellular response to stimulus cellular response to nutrient levels response to nutrient levels response to stimulus cellular response to stress response to stress response to starvation cellular response to glucose starvation cellular response to starvation positive regulation of biological process positive regulation of cell cycle mitotic cell cycle regulation of mitotic cell cycle positive regulation of mitotic cell cycle cell cycle regulation of cell cycle positive regulation of cellular process	cellular anatomical structure intracellular anatomical structure cytoplasm cytosol

InterPro: Protein Family Classification InterPro Database Homepage

Chains	Accession	Name	Type
A, B	IPR029055	Nucleophile aminohydrolases, N-terminal	Homologous Superfamily
A, B	IPR014729	Rossmann-like alpha/beta/alpha sandwich fold	Homologous Superfamily
A, B	IPR033738	Asparagine synthase, N-terminal domain	Domain
A, B	IPR006426	Asparagine synthase, glutamine-hydrolyzing	Family
A, B	IPR017932	Glutamine amidotransferase type 2 domain	Domain
A, B	IPR001962	Asparagine synthase	Domain
A, B	IPR050795	Asparagine Synthetase	Family

Pharos: Disease Associations Pharos Homepage Annotation

Chains	Drug Target	Associated Disease
A, B	Pharos: P08243	congenital microcephaly - severe encephalopathy - progressive cerebral atrophy syndrome liver cancer Liver Cirrhosis, Experimental malignant mesothelioma nasopharyngeal carcinoma pancreatic ductal adenocarcinoma pilocytic astrocytoma adrenal cortex carcinoma atypical teratoid rhabdoid tumor dermatomyositis intellectual disability lung cancer malignant colon neoplasm malignant pancreatic neoplasm non-small cell lung carcinoma congenital microcephaly - severe encephalopathy - progressive cerebral atrophy syndrome liver cancer Liver Cirrhosis, Experimental malignant mesothelioma nasopharyngeal carcinoma pancreatic ductal adenocarcinoma pilocytic astrocytoma adrenal cortex carcinoma atypical teratoid rhabdoid tumor dermatomyositis intellectual disability lung cancer malignant colon neoplasm malignant pancreatic neoplasm non-small cell lung carcinoma pancreatic intraductal papillary-mucinous neoplasm with low grade dysplasia plasma cell myeloma astrocytic tumor esophageal adenocarcinoma juvenile dermatomyositis lung carcinoma malignant ependymoma myelodysplastic syndrome ovarian cancer Pick disease polycystic ovary syndrome attention deficit hyperactivity disorder, inattentive type cystic fibrosis glioblastoma liver neoplasm lysosomal lipid storage disorder

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729. RCSB PDB uses resources of the National Energy Research Scientific Computing Center (NERSC), a Department of Energy User Facility.